A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.

The global Pharmaceutical CDMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO Services.

Report Scope

The Pharmaceutical CDMO Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical CDMO Services Market Report

Report Metric	Details
Report Name	Pharmaceutical CDMO Services Market
CAGR	5%
Segment by Type	Drug Substance Development and Manufacturing Specialized Services Lab-based Services
Segment by Application	Innovative Medicine Patented Drug Patent Expired Drug
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited, Piramal Pharma Solutions, Siegfried Ltd, Fareva Group, FAMAR Health Care Services
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CDMO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical CDMO Services Market report?

Ans: The main players in the Pharmaceutical CDMO Services Market are Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited, Piramal Pharma Solutions, Siegfried Ltd, Fareva Group, FAMAR Health Care Services

What are the Application segmentation covered in the Pharmaceutical CDMO Services Market report?

Ans: The Applications covered in the Pharmaceutical CDMO Services Market report are Innovative Medicine, Patented Drug, Patent Expired Drug

What are the Type segmentation covered in the Pharmaceutical CDMO Services Market report?

Ans: The Types covered in the Pharmaceutical CDMO Services Market report are Drug Substance Development and Manufacturing, Specialized Services, Lab-based Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drug Substance Development and Manufacturing

1.2.3 Specialized Services

1.2.4 Lab-based Services

1.3 Market by Application

1.3.1 Global Pharmaceutical CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Innovative Medicine

1.3.3 Patented Drug

1.3.4 Patent Expired Drug

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical CDMO Services Market Perspective (2019-2030)

2.2 Pharmaceutical CDMO Services Growth Trends by Region

2.2.1 Global Pharmaceutical CDMO Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmaceutical CDMO Services Historic Market Size by Region (2019-2024)

2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Region (2025-2030)

2.3 Pharmaceutical CDMO Services Market Dynamics

2.3.1 Pharmaceutical CDMO Services Industry Trends

2.3.2 Pharmaceutical CDMO Services Market Drivers

2.3.3 Pharmaceutical CDMO Services Market Challenges

2.3.4 Pharmaceutical CDMO Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical CDMO Services Players by Revenue

3.1.1 Global Top Pharmaceutical CDMO Services Players by Revenue (2019-2024)

3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2019-2024)

3.2 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmaceutical CDMO Services Revenue

3.4 Global Pharmaceutical CDMO Services Market Concentration Ratio

3.4.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2023

3.5 Pharmaceutical CDMO Services Key Players Head office and Area Served

3.6 Key Players Pharmaceutical CDMO Services Product Solution and Service

3.7 Date of Enter into Pharmaceutical CDMO Services Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CDMO Services Breakdown Data by Type

4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2019-2024)

4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2025-2030)

5 Pharmaceutical CDMO Services Breakdown Data by Application

5.1 Global Pharmaceutical CDMO Services Historic Market Size by Application (2019-2024)

5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmaceutical CDMO Services Market Size (2019-2030)

6.2 North America Pharmaceutical CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pharmaceutical CDMO Services Market Size by Country (2019-2024)

6.4 North America Pharmaceutical CDMO Services Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical CDMO Services Market Size (2019-2030)

7.2 Europe Pharmaceutical CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pharmaceutical CDMO Services Market Size by Country (2019-2024)

7.4 Europe Pharmaceutical CDMO Services Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical CDMO Services Market Size (2019-2030)

8.2 Asia-Pacific Pharmaceutical CDMO Services Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2019-2024)

8.4 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutical CDMO Services Market Size (2019-2030)

9.2 Latin America Pharmaceutical CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pharmaceutical CDMO Services Market Size by Country (2019-2024)

9.4 Latin America Pharmaceutical CDMO Services Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical CDMO Services Market Size (2019-2030)

10.2 Middle East & Africa Pharmaceutical CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2019-2024)

10.4 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Recipharm AB

11.1.1 Recipharm AB Company Detail

11.1.2 Recipharm AB Business Overview

11.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction

11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.1.5 Recipharm AB Recent Development

11.2 AMRI Global

11.2.1 AMRI Global Company Detail

11.2.2 AMRI Global Business Overview

11.2.3 AMRI Global Pharmaceutical CDMO Services Introduction

11.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.2.5 AMRI Global Recent Development

11.3 Patheon N.V.

11.3.1 Patheon N.V. Company Detail

11.3.2 Patheon N.V. Business Overview

11.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction

11.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.3.5 Patheon N.V. Recent Development

11.4 Aenova Group

11.4.1 Aenova Group Company Detail

11.4.2 Aenova Group Business Overview

11.4.3 Aenova Group Pharmaceutical CDMO Services Introduction

11.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.4.5 Aenova Group Recent Development

11.5 Catalent, Inc.

11.5.1 Catalent, Inc. Company Detail

11.5.2 Catalent, Inc. Business Overview

11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction

11.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.5.5 Catalent, Inc. Recent Development

11.6 Amatsigroup

11.6.1 Amatsigroup Company Detail

11.6.2 Amatsigroup Business Overview

11.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction

11.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.6.5 Amatsigroup Recent Development

11.7 WuXi AppTec Group

11.7.1 WuXi AppTec Group Company Detail

11.7.2 WuXi AppTec Group Business Overview

11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction

11.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.7.5 WuXi AppTec Group Recent Development

11.8 Strides Pharma Science Limited

11.8.1 Strides Pharma Science Limited Company Detail

11.8.2 Strides Pharma Science Limited Business Overview

11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction

11.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.8.5 Strides Pharma Science Limited Recent Development

11.9 Piramal Pharma Solutions

11.9.1 Piramal Pharma Solutions Company Detail

11.9.2 Piramal Pharma Solutions Business Overview

11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction

11.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.9.5 Piramal Pharma Solutions Recent Development

11.10 Siegfried Ltd

11.10.1 Siegfried Ltd Company Detail

11.10.2 Siegfried Ltd Business Overview

11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction

11.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.10.5 Siegfried Ltd Recent Development

11.11 Fareva Group

11.11.1 Fareva Group Company Detail

11.11.2 Fareva Group Business Overview

11.11.3 Fareva Group Pharmaceutical CDMO Services Introduction

11.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.11.5 Fareva Group Recent Development

11.12 FAMAR Health Care Services

11.12.1 FAMAR Health Care Services Company Detail

11.12.2 FAMAR Health Care Services Business Overview

11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction

11.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2019-2024)

11.12.5 FAMAR Health Care Services Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Strides Pharma Science Limited

Piramal Pharma Solutions

Siegfried

Fareva Group

Famar Health Care Services

List of Tables

Table 1. Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Drug Substance Development and Manufacturing

Table 3. Key Players of Specialized Services

Table 4. Key Players of Lab-based Services

Table 5. Global Pharmaceutical CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Pharmaceutical CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Pharmaceutical CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Pharmaceutical CDMO Services Market Share by Region (2019-2024)

Table 9. Global Pharmaceutical CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Pharmaceutical CDMO Services Market Share by Region (2025-2030)

Table 11. Pharmaceutical CDMO Services Market Trends

Table 12. Pharmaceutical CDMO Services Market Drivers

Table 13. Pharmaceutical CDMO Services Market Challenges

Table 14. Pharmaceutical CDMO Services Market Restraints

Table 15. Global Pharmaceutical CDMO Services Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Pharmaceutical CDMO Services Market Share by Players (2019-2024)

Table 17. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Services as of 2023)

Table 18. Ranking of Global Top Pharmaceutical CDMO Services Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Pharmaceutical CDMO Services Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Pharmaceutical CDMO Services Product Solution and Service

Table 22. Date of Enter into Pharmaceutical CDMO Services Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharmaceutical CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2019-2024)

Table 26. Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2025-2030)

Table 28. Global Pharmaceutical CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2019-2024)

Table 30. Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2025-2030)

Table 32. North America Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Pharmaceutical CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Pharmaceutical CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Pharmaceutical CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Pharmaceutical CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Pharmaceutical CDMO Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Pharmaceutical CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Pharmaceutical CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Pharmaceutical CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 47. Recipharm AB Company Detail

Table 48. Recipharm AB Business Overview

Table 49. Recipharm AB Pharmaceutical CDMO Services Product

Table 50. Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 51. Recipharm AB Recent Development

Table 52. AMRI Global Company Detail

Table 53. AMRI Global Business Overview

Table 54. AMRI Global Pharmaceutical CDMO Services Product

Table 55. AMRI Global Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 56. AMRI Global Recent Development

Table 57. Patheon N.V. Company Detail

Table 58. Patheon N.V. Business Overview

Table 59. Patheon N.V. Pharmaceutical CDMO Services Product

Table 60. Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 61. Patheon N.V. Recent Development

Table 62. Aenova Group Company Detail

Table 63. Aenova Group Business Overview

Table 64. Aenova Group Pharmaceutical CDMO Services Product

Table 65. Aenova Group Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 66. Aenova Group Recent Development

Table 67. Catalent, Inc. Company Detail

Table 68. Catalent, Inc. Business Overview

Table 69. Catalent, Inc. Pharmaceutical CDMO Services Product

Table 70. Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 71. Catalent, Inc. Recent Development

Table 72. Amatsigroup Company Detail

Table 73. Amatsigroup Business Overview

Table 74. Amatsigroup Pharmaceutical CDMO Services Product

Table 75. Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 76. Amatsigroup Recent Development

Table 77. WuXi AppTec Group Company Detail

Table 78. WuXi AppTec Group Business Overview

Table 79. WuXi AppTec Group Pharmaceutical CDMO Services Product

Table 80. WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 81. WuXi AppTec Group Recent Development

Table 82. Strides Pharma Science Limited Company Detail

Table 83. Strides Pharma Science Limited Business Overview

Table 84. Strides Pharma Science Limited Pharmaceutical CDMO Services Product

Table 85. Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 86. Strides Pharma Science Limited Recent Development

Table 87. Piramal Pharma Solutions Company Detail

Table 88. Piramal Pharma Solutions Business Overview

Table 89. Piramal Pharma Solutions Pharmaceutical CDMO Services Product

Table 90. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 91. Piramal Pharma Solutions Recent Development

Table 92. Siegfried Ltd Company Detail

Table 93. Siegfried Ltd Business Overview

Table 94. Siegfried Ltd Pharmaceutical CDMO Services Product

Table 95. Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 96. Siegfried Ltd Recent Development

Table 97. Fareva Group Company Detail

Table 98. Fareva Group Business Overview

Table 99. Fareva Group Pharmaceutical CDMO Services Product

Table 100. Fareva Group Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 101. Fareva Group Recent Development

Table 102. FAMAR Health Care Services Company Detail

Table 103. FAMAR Health Care Services Business Overview

Table 104. FAMAR Health Care Services Pharmaceutical CDMO Services Product

Table 105. FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2019-2024) & (US$ Million)

Table 106. FAMAR Health Care Services Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutical CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Pharmaceutical CDMO Services Market Share by Type: 2023 VS 2030

Figure 3. Drug Substance Development and Manufacturing Features

Figure 4. Specialized Services Features

Figure 5. Lab-based Services Features

Figure 6. Global Pharmaceutical CDMO Services Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Pharmaceutical CDMO Services Market Share by Application: 2023 VS 2030

Figure 8. Innovative Medicine Case Studies

Figure 9. Patented Drug Case Studies

Figure 10. Patent Expired Drug Case Studies

Figure 11. Pharmaceutical CDMO Services Report Years Considered

Figure 12. Global Pharmaceutical CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Pharmaceutical CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Pharmaceutical CDMO Services Market Share by Region: 2023 VS 2030

Figure 15. Global Pharmaceutical CDMO Services Market Share by Players in 2023

Figure 16. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Services as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2023

Figure 18. North America Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Pharmaceutical CDMO Services Market Share by Country (2019-2030)

Figure 20. United States Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Pharmaceutical CDMO Services Market Share by Country (2019-2030)

Figure 24. Germany Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Pharmaceutical CDMO Services Market Share by Region (2019-2030)

Figure 32. China Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Pharmaceutical CDMO Services Market Share by Country (2019-2030)

Figure 40. Mexico Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Pharmaceutical CDMO Services Market Share by Country (2019-2030)

Figure 44. Turkey Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Pharmaceutical CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 47. AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 48. Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 49. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 50. Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 51. Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 52. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 53. Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 54. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 55. Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 56. Fareva Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 57. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical CDMO Services Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

CDMO Market

120 Pages

Type: Report

Code: QYRE-Auto-5Q14261

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Grade Silica - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-38W13955

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Pharma Grade Sodium Hydroxide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-30U13946

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Sorbitol Liquid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-23N13862

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pharmaceutical CDMO Services Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-6M1200

Global Pharmaceutical CDMO Services Market Research Report 2024

FEATURED COMPANIES

Pharmaceutical CDMO Services Market Size

Pharmaceutical CDMO Services Market

Report Scope

Scope of Pharmaceutical CDMO Services Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Pharmaceutical CDMO Services Market report?

What are the Application segmentation covered in the Pharmaceutical CDMO Services Market report?

What are the Type segmentation covered in the Pharmaceutical CDMO Services Market report?

FEATURED COMPANIES

RELATED REPORTS